ID: ALA227040

Max Phase: Preclinical

Molecular Formula: C29H50N6O9

Molecular Weight: 626.75

Molecule Type: Protein

Associated Items:

Representations

Canonical SMILES:  CC(C)C[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H]1CCCN1)C(=O)O

Standard InChI:  InChI=1S/C29H50N6O9/c1-15(2)10-19(32-23(36)14-31-25(39)18-8-7-9-30-18)26(40)33-20(11-16(3)4)27(41)34-21(13-24(37)38)28(42)35-22(29(43)44)12-17(5)6/h15-22,30H,7-14H2,1-6H3,(H,31,39)(H,32,36)(H,33,40)(H,34,41)(H,35,42)(H,37,38)(H,43,44)/t18-,19-,20-,21-,22-/m0/s1

Standard InChI Key:  GWXBPAMZJOOZQY-YFNVTMOMSA-N

Associated Targets(non-human)

Hypothalamus (44 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: ProteinTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 626.75Molecular Weight (Monoisotopic): 626.3639AlogP: -0.51#Rotatable Bonds: 19
Polar Surface Area: 232.13Molecular Species: ZWITTERIONHBA: 8HBD: 8
#RO5 Violations: 2HBA (Lipinski): 15HBD (Lipinski): 8#RO5 Violations (Lipinski): 3
CX Acidic pKa: 3.59CX Basic pKa: 9.50CX LogP: -2.99CX LogD: -5.81
Aromatic Rings: 0Heavy Atoms: 44QED Weighted: 0.09Np Likeness Score: -0.02

References

1. Rego JL, Leprince J, Luu-The V, Pelletier G, Tonon MC, Vaudry H..  (2007)  Structure-activity relationships of a series of analogs of the endozepine octadecaneuropeptide (ODN(11)(-)(18)) on neurosteroid biosynthesis by hypothalamic explants.,  50  (13): [PMID:17550241] [10.1021/jm0610548]

Source